Position. Employee shall continue in the employ of Albany performing, in good faith, and to the best of his abilities, the duties of Chief Financial Officer and such other duties that may be assigned to him from time to time, by his supervisor.

Position. Executive is employed as the Company’s Chief Financial Officer and shall have the duties and responsibilities assigned by the Company’s Chief Executive Officer (“CEO”) both upon initial hire and as may be reasonably assigned from time to time. Executive shall perform faithfully and diligently all duties assigned to Executive. The Company reserves the right to modify Executive’s position and duties at any time in its sole and absolute discretion, subject to Section 7.3 below.

Position. Subject to the terms and provisions of this Agreement, the Company shall cause the Director to be appointed, and the Director hereby agrees to serve the Company in such position upon the terms and conditions hereinafter set forth, provided however, that the Director’s continued service on the Board of Directors of the Company (the “Board”) after the initial one-year term on the Board shall be subject to any necessary approval by the Company’s stockholders.

Position. You shall serve as the Executive Vice President, Chief Financial Officer of the Company or in such other or additional positions as the Company’s President, Chief Executive Officer and/or Board of Directors (the “Board”) may determine from time to time. In such position, You shall # report to the Company’s President or such other person as the Company may designate from time to time, and # have such duties, authority and responsibility as shall be determined from time to time by the Company’s President, Chief Executive Officer and/or Board.

Position. Your initial title will be Chief Scientific Officer. Effective as of June 1, 2016, you will report to the Company’s CEO and you shall have such powers and duties as may from time to time be prescribed by the Chairman of the Board of Directors of the Company (the “Board”) or the President, provided that such duties are consistent with the position of Chief Scientific Officer or other positions that you may hold from time to time. This is initially a part-time position and you will be required to devote 3 days per week to the business and affairs of the Company. During your employment with the Company, you will not engage in any outside employment, consulting or other business activity (whether full-time or part-time) without the Company’s written consent, which shall not be unreasonably withheld, other than the for profit and non-profit consulting activities in which you currently engage (which have been previously disclosed to the Company), or any work for BridgeBio Pharma, LLC (“BridgeBio”) under that certain letter agreement dated June 10, 2016, provided that such consulting activities or future work for a non-profit do not materially interfere with your performance of duties to the Company under this letter agreement. By signing this letter agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company.

Position. During the Contract Period the Executive shall be employed in a senior executive position, with duties and responsibilities substantially similar with the Executive’s duties and responsibilities as in effect immediately prior to the Change in Control. The Executive shall devote his/her full time and attention to the business of the Company, and shall not during the Contract Period be engaged in any other business activity. This Section shall not be construed as preventing the Executive from managing any of his/her investments which do not require any service on his/her part in the operation of such investments.

Position. During the Employment Term, Executive shall serve as the Senior Executive Vice President of the Company and President of Banking of the Bank.

Position. During the Term, on the terms and subject to the conditions set forth in this Agreement, the Company shall employ the Executive and the Executive shall serve the Company as “Chief Executive Officer” and “Chief Scientific Officer.” The Executive shall report to the Company’s Board of Directors (the “Board”).

Position. The Company hereby employs Employee as Chief Operating Officer of the Company. Employee shall report directly to the President/Chief Executive Officer of the Company (the “CEO”) and shall have the duties, authority and responsibilities customarily held by a person holding the position Chief Operating Officer in companies engaged in business similar to the Company’s business and of similar size to the Company. Employee shall render such other services as may be reasonably assigned to him from time to time by the CEO.

Good Reason means the occurrence of one or more of the following events without Executive’s express consent: # a material reduction of Executive’s Base Salary (except where there is a pro-rata reduction applicable to the management team generally), or # a material change in the geographic location at which Executive must perform her services; provided, that in no instance will the relocation of Executive to a facility or a location of fifty (50) miles or less from Executive’s then current office location be deemed material for purposes of this Agreement, or # a material reduction of Executive’s authorities, duties or responsibilities, including after a Change of Control # the assignment of responsibilities, duties, reporting relationship or position that are not at least the substantial functional equivalent of the Executive’s position occupied immediately preceding the Change of Control, including the assignment of responsibilities, duties, reporting relationship or position that are not in a substantive area that is consistent with the Executive’s experience and the position occupied prior to the Change of Control or # a material diminution in the budget and number of subordinates over which the Executive’s retains authority; 8. Limitation on Payments; [Section 280G]. If any severance or other benefits payable to Executive under this Agreement or otherwise (the “Payments”) # are “parachute payments” within the meaning of Code Section 280G and # but for this Section 8, would be subject to the “golden parachute” excise tax imposed by Section 4999 of the Code, then the Payments will reduced to a level that will result in no tax under Code Section 4999 unless it would be better economically for Executive to receive all of the Payments and pay the excise tax. If a reduction in the Payments is necessary for this purpose, then the reduction will occur in the following order # reduction of the cash severance payments; # reduction of continued employee benefits; and # cancellation of accelerated vesting of equity awards . If the acceleration of vesting of equity award compensation is to be reduced, that acceleration of vesting will be cancelled in the reverse order of the date of grant of Executive’s equity awards. Any determination required under this Section 8 will be made in writing by a nationally recognized accounting firm chosen by the Company immediately prior to a Change of Control and paid for by the Company and that determination will be conclusive and binding upon Executive and the Company for all purposes.